| Literature DB >> 31341474 |
Fatima Ibrahim Al-Yatama1, Fatemah AlOtaibi2, Maie Dawoud Al-Bader2, Kamal A Al-Shoumer3.
Abstract
Many Arab women in the Gulf region cover their bodies for cultural and religious reasons, limiting the skin's exposure to sunlight and therefore its ability to synthesize vitamin D. The aim of this study is to determine whether the clothing style of Kuwaiti premenopausal women affects their vitamin D status, bone marker expression, and bone density. Three groups of healthy unmarried single Kuwaiti females (20-35 years old; n=30 per group) were recruited randomly from the general community: a control group who wear Western-style clothing (unveiled group), a group who wear a hejab that covers the whole body except for the face and hands (hejab group), and a group who wear a black veil with the entire body covered (veiled group). Bone mineral density (BMD), bone markers (procollagen type 1 N-terminal propeptide [P1NP], osteocalcin, and β-CrossLaps), 25-hydroxy vitamin D, intact parathyroid hormone [iPTH], and calcitonin were measured. The bone marker osteocalcin was significantly higher in the hejab group compared to the control group, whereas P1NP and β-CrossLaps were significantly higher in the veiled group compared to the control group. 25-hydroxy vitamin D, iPTH, calcitonin, and BMD were not significantly different across the three groups despite the observed elevation in bone turnover markers. The majority of participants in all three groups exhibited vitamin D deficiency; however, the lowest vitamin D levels were observed among the hejab and veiled participants. These findings suggest that clothing style may contribute to vitamin D deficiency in young Kuwaiti women.Entities:
Year: 2019 PMID: 31341474 PMCID: PMC6612396 DOI: 10.1155/2019/6794837
Source DB: PubMed Journal: Int J Endocrinol ISSN: 1687-8337 Impact factor: 3.257
Biometric data.
| Unveiled (n=30) | Hejab (n=30) | Veiled (n=30) | |
|---|---|---|---|
| Age | 21.93 ± 0.358 | 24.1 ± 0.606 | 22.15 ± 0.395 |
| Height (m) | 1.6 ± 0.011 | 1.6 ± 0.013 | 1.59 ± 0.012 |
| Weight (kg) | 62.64 ± 2.57 | 65.35 ± 3.75 | 67.76 ± 2.71 |
| BMI (kg/m2) | 24.46 ± 1.11 | 25.15 ± 1.27 | 26.62 ± 1.01 |
All variables are expressed as the mean ± standard error of the mean (SEM). Pearson's chi-squared test was used for comparisons between groups; no significant differences were detected. BMI, body mass index.
Demographic information.
| Unveiled (n=30) | Hejab (n=30) | Veiled (n=30) | |
|---|---|---|---|
| Exercise | 11(36.7%) | 12 (40%) | 15 (50%) |
| Smoking | 3 (10%) | 0 (0%) | 0 (0%) |
| Milk Consumption | 21 (70%) | 25 (83.3%) | 22 (73.3%) |
| History of Osteoporosis | 8 (26.7%) | 7 (23.3%) | 2 (6.7%) |
| Supplement Intake | 5 (16.7%) | 1 (3.3%) | 5 (16.7%) |
All variables are expressed as the number of participants per group (percentage). Pearson's chi-squared test was used for comparisons between groups; no significant differences were detected.
Indoor and outdoor sun exposure.
| Unveiled (n=30) | Hejab (n=30) | Veiled (n=30) | ||
|---|---|---|---|---|
| Frequency (%) | ||||
| Duration of Indoor Sun Exposure (minutes) | 0 | 20 (66.7%) | 16 (53.3%) | 16 (53.3%) |
| <30 | 10 (33.3%) | 8 (27%) | 9 (30%) | |
| 30-60 | 3 (10%) | 3 (10%) | ||
| 60-120 | 2 (7%) | 1 (3%) | ||
| >120 | 1 (3%) | 1 (3%) | ||
|
| ||||
| Duration of Outdoor Sun Exposure (minutes) | 0 | 1 (3.3%) | 1 (3.3%) | 0 (0%) |
| <30 | 13 (43.3%) | 12 (40%) | 13 (43.3%) | |
| 30-60 | 14 (46.7%) | 13 (43.3%) | 13 (43.3%) | |
| 60-120 | 2 (6.7%) | 4 (13.3%) | 1 (3.3%) | |
| >120 | 0 (0%) | 0 (0%) | 3 (10%) | |
|
| ||||
| Time of Exposure | Morning | 10 (33.3%) | 9 (30%) | 18 (60%) |
| Noon | 16 (53.3%) | 16 (53%) | 11 (37%) | |
| Afternoon | 4 (13.3%) | 1 (3.3%) | ||
|
| ||||
| Use of Sun Protection | No | 25 (83.3%) | 29 (96.7%) | 25 (83.3%) |
| Yes | 5 (16.7%) | 1 (3.3%) | 5 (16.7) | |
All variables are expressed as the number of participants per group (percentage). Pearson's chi-squared test was used for comparisons between groups; no significant differences were detected.
Fasting biochemical variables.
| Unveiled (n=30) | Hejab (n=30) | Veiled (n=30) | Reference Range | |
|---|---|---|---|---|
| GLUC | 3.8 ± 0.2 | 3.6 ± 0.1 | 3.9 ± 0.2 | 3.9-6.1 mmol/L |
|
| ||||
|
| ||||
| BUN | 3.21 ± 0.17 | 3.25 ± 0.2 | 2.81 ± 0.15 | 2.5-6.6 mmol/L |
| CREA | 41.2 ± 2.62 | 41.8 ± 1.85 | 38.7 ± 2.32 | 60-120 |
| URIC | 227 ± 9.23 | 235 ± 9.17 | 215 ± 10.9 | 150-400 |
| Na | 131.3 ± 3.75 | 128.5 ± 2.59 | 129.3 ± 2.7 | 135-148 mmol/L |
| K | 3.75 ± 0.11 | 3.84 ± 0.11 | 3.64 ± 0.1 | 3.5-5.3 mmol/L |
|
| ||||
|
| ||||
| ALB | 33.5 ± 1.74 | 31.5 ± 1.11 | 34.1 ± 1.48 | 35-47 g/L |
| ALP | 34.1 ± 2.97 | 32.6 ± 1.91 | 36.1 ± 3.1 | 26-88 IU/L |
| ALT | 11 ± 1.08 | 8.94 ± 0.53 | 9.25 ± 0.94 | 10-60 IU/L |
| AST | 15 ± 1 | 13 ± 1.1 | 14 ± 1 | 10-42 IU/L |
| TP | 58 ± 3.03 | 59.6 ± 4.51 | 61.1 ± 2.3 | 63-80 g/L |
|
| ||||
|
| ||||
| CHOL | 3.19 ± 0.23 | 3.39 ± 0.14 | 3.3 ± 0.19 | 3-5.2 mmol/L |
| TG | 0.67 ± 0.06 | 0.83 ± 0.08 | 0.66 ± 0.05 | 0-2 mmol/L |
| HDL | 1.01 ± 0.08 | 1.13 ± 0.04 | 3.29 ± 2.06 | 0.9-2.5 mmol/L |
|
| ||||
|
| ||||
| Corrected Ca | 2.23 ± 0.035 | 2.25 ± 0.199 | 2.22 ± 0.035 | 2.2-2.6 mmol/L |
| PO4 | 0.89 ± 0.06 | 0.92 ± 0.03 | 1.04 ± 0.06 | 0.8-1.4 mmol/L |
| IRON | 16.3 ± 1.57 | 16.6 ± 1.36 | 14.4 ± 1.8 | 11-31 |
| TRFN | 2.7 ± 0.08 | 3.5 ± 0.1 | 3.3 ± 0.16 | 2.1-3.6 g/L |
All variables are expressed as the mean ± standard error of the mean (SEM). GLUC, glucose; BUN, blood urea nitrogen; CREA, creatinine; URIC, uric acid; Na, sodium; K, potassium; ALB, albumin; ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; TP, total protein; CHOL, cholesterol; TG, triglycerides; HDL, high-density lipoprotein; Ca, calcium; PO4, phosphate; TRFN, transferrin.
Bone mineral density comparisons.
| Unveiled (n=30) | Hejab (n=30) | Veiled (n=30) | |
|---|---|---|---|
| Left Femoral Neck | |||
| BMD (g/cm2) | 0.99 ± 0.02 | 0.97 ± 0.028 | 0.98 ± 0.022 |
| Z-score | -0.43 ± 0.16 | -0.62 ± 0.22 | -0.58 ± 0.17 |
| Right Femoral Neck | |||
| BMD (g/cm2) | 0.99 ± 0.02 | 0.96 ± 0.03 | 0.98 ± 0.019 |
| Z-score | -0.41 ± 0.16 | -0.66 ± 0.195 | -0.61 ± 0.15 |
| Lumbar Spine (L2-L4) | |||
| BMD (g/cm2) | 1.19 ± 0.02 | 1.17 ± 0.025 | 1.24 ± 0.02 |
| BMC (g) | 45.8 ± 1.39 | 44.3 ± 1.45 | 49.4 ± 1.53 |
| Z-score | 0.028 ± 0.18 | -0.24 ± 0.21 | 0.27 ± 0.16 |
| Total Body | |||
| BMD (g/cm2) | 1.13 ± 0.014 | 1.12 ± 0.018 | 1.16 ± 0.014 |
| BMC (g) | 2340.3 ± 59.81 | 2298.5 ± 54.6 | 2384.7 ± 64.32 |
| Z-score | 0.2 ± 0.13 | -0.02 ± 0.17 | 0.25 ± 0.12 |
All variables are expressed as the mean ± standard error of the mean (SEM). Independent t-tests were conducted for comparisons between groups; no significant differences were detected. BMD, bone mineral density; BMC, bone mineral contents.
Bone turnover marker comparisons between the unveiled and hejab groups.
| Bone Marker | Unveiled | Veiled | Hejab | Reference Range |
|---|---|---|---|---|
| (n=30) | (n=30) | (n=30) | ng/ml | |
| P1NP | 55.13 ± 3.69 | 73.8 ± 4.52 | 62.12 ± 4.6 | 19-100 |
| Osteocalcin | 23.22 ± 1.39 | 26.63 ± 1.46 | 31.23 ± 2.52 | 0.5-300 |
|
| 0.39 ± 0.03 | 0.54 ± 0.03 | 0.41 ± 0.03 | 0.112-1.081 |
All variables are expressed as the mean ± standard error of the mean (SEM). The Mann-Whitney test was conducted for comparisons between groups. P1NP and β-CrossLaps were significantly higher in the veiled group compared to unveiled one; ∗∗p<0.01 and ∗∗∗p=0.001, respectively.
Osteocalcin was significantly higher in the hejab group compared to unveiled group; ∗p<0.05.
Figure 1The mean (± standard error of the mean) 25-hydroxyvitamin D (25(OH)D) concentrations among the unveiled, hejab, and veiled groups. A decreasing trend was observed across the three groups.
Figure 2The mean (± standard error of the mean) intact parathyroid hormone (iPTH) concentrations among the unveiled, hejab, and veiled groups. An increasing trend was observed across the three groups.
Figure 3The mean (± standard error of the mean) calcitonin concentrations among the unveiled, hejab, and veiled groups. A decreasing trend was observed across the three groups.
Intact parathyroid hormone levels across groups.
| iPTH | Unveiled | Hejab | Veiled |
| |
|---|---|---|---|---|---|
| (n=30) | (n=30) | (n=30) | |||
| Normal (≤65 pg/ml) | Frequency | 22 | 24 | 18 | NS |
| % | 34.40% | 37.50% | 28.10% | ||
| High (>65 pg/ml) | Frequency | 8 | 5 | 12 | NS |
| % | 32% | 20% | 48% | ||
All variables are expressed as the number of participants per group (percentage). Pearson's chi-squared test was conducted for comparisons between groups. iPTH, intact parathyroid hormone; NS, not significant.